372 related articles for article (PubMed ID: 3549802)
1. Safety and efficacy of topical minoxidil in the management of androgenetic alopecia.
Rietschel RL; Duncan SH
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):677-85. PubMed ID: 3549802
[TBL] [Abstract][Full Text] [Related]
2. Androgenetic alopecia: treatment results with topical minoxidil.
Roberts JL
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):705-10. PubMed ID: 3549805
[TBL] [Abstract][Full Text] [Related]
3. Androgenetic alopecia treated with topical minoxidil.
De Villez RL
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):669-72. PubMed ID: 3549800
[TBL] [Abstract][Full Text] [Related]
4. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
Koperski JA; Orenberg EK; Wilkinson DI
Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
[TBL] [Abstract][Full Text] [Related]
5. Use of topical minoxidil therapy for androgenetic alopecia in women.
Jacobs JP; Szpunar CA; Warner ML
Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
[TBL] [Abstract][Full Text] [Related]
6. Use of topical minoxidil in the treatment of male pattern baldness.
Savin RC
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):696-704. PubMed ID: 3549804
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
8. Topical minoxidil in early androgenetic alopecia.
Kreindler TG
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):718-24. PubMed ID: 3549807
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
10. Dose-response study of topical minoxidil in male pattern alopecia.
Shupack JL; Kassimir JJ; Thirumoorthy T; Reed ML; Jondreau L
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):673-6. PubMed ID: 3549801
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of topical minoxidil in male pattern baldness.
Katz HI; Hien NT; Prawer SE; Goldman SJ
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):711-8. PubMed ID: 3549806
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
[TBL] [Abstract][Full Text] [Related]
14. Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy.
Price VH
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):737-44. PubMed ID: 3549810
[TBL] [Abstract][Full Text] [Related]
15. Topical minoxidil therapy in hereditary androgenetic alopecia.
De Villez RL
Arch Dermatol; 1985 Feb; 121(2):197-202. PubMed ID: 3883902
[TBL] [Abstract][Full Text] [Related]
16. Treatment of female androgenetic alopecia with minoxidil 2%.
Whiting DA; Jacobson C
Int J Dermatol; 1992 Nov; 31(11):800-4. PubMed ID: 1428436
[TBL] [Abstract][Full Text] [Related]
17. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
Price VH; Menefee E; Strauss PC
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):717-21. PubMed ID: 10534633
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
19. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
